Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Neuroblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 14 Temozolomide 10 Magnetic Resonance Spectroscopy 10 dinutuximab 9 Biopsy 9 X-Rays 8 Specimen Handling 8 Irinotecan 8 Phantoms, Imaging 7 fludarabine 6 Topotecan 6 Nuclear Medicine Department, Hospital 6 Vincristine 5 3-Iodobenzylguanidine 5 sargramostim 4 fludarabine phosphate 4 Melphalan 4 Isotretinoin 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Etoposide 4 tipifarnib 3 Radiotherapy 3 Filgrastim 3 Doxorubicin 3 Colony-Stimulating Factors 3 Carboplatin 3 ulixertinib 2 tazemetostat 2 selpercatinib 2 saponin QA-21V1 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Antibodies × 90 days × Clear all

NCT02914405 2026-04-28

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡